Pfizer Stock News

The man, who had returned from New York, tested positive for COVID-19 in a test conducted at the airport on November 9, after which his samples were sent for genome sequencing.

Pfizer will start testing Covid-19 vaccine booster doses in children aged six months to five years old after finding that its lower-dose shot may not provide enough protection in one age group. Read Full Article at RT.com

The Centre has advised people to avoid non-essential travel and mass gatherings and keep New Year celebrations at low intensity.

It will be bizarre to the world population that the Chief Executive Officer/ Chairman of a leading COVID-19 vaccine producer, Pfizer is yet to receive the vaccine jab. A video trending on tiktok relayed the Pfizer CEO, Albert Bourla, to have purportedly admitted in a media interaction that he has not received COVID-19 vaccine, The post Pfizer CEO/Chairman yet to receive COVID-19 vaccine appeared first on National Daily Newspaper .

Pfizer Inc said on Friday the COVID-19 pandemic could extend through next year and announced plans to develop a three-dose vaccine regimen for children ages 2 to 16, a move that could delay its authorisation. The U.S. pharmaceutical company made its comments as European countries geared up for further travel and social restrictions and a []

The US Centers for Disease Control and Prevention (CDC) changed its recommendations for Covid-19 vaccines Thursday to make clear that shots made by Moderna and Pfizer/BioNTech are preferred over Johnson & Johnsons vaccine. The new recommendation now reads, mRNA vaccines are preferred over the Janssen Covid-19 vaccine for the prevention of Covid-19 for those 18 The post CDC Recommends Pfizer and Moderna Vaccines Over J&J Due to Rare Side Effects appeared first on HillReporter.com .

Pfizer said it wants to test a third dose of the Covid-19 vaccine in the under-fives

A move to redefine the term fully vaccinated as three shots of Pfizer or Moderna is on the table, Dr. Anthony Fauci said Friday.

The surge of infections with COVID-19 Omicron variant was a big concern for investors as the key stock market indices in the United States ended the session in the red on Friday. The Dow Jones fell 1.48% with Goldman Sachs dropping 3.92%. The tech heavy Nasdaq 100 also fell by 0.39% while the S&P 500 declined by 1.03%. US National Institute of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci on Friday said that the newly-detected strain is beyond doubt more transmissible than its predecessors. Pfizer In a presentation revealed during Pfizers investor call on Friday, the company noted thta it assumes that the COVID-19 pandemic will turn into an endemic in 2024. This comes as the firm announced a small-scale study aimed at testing its modified coronavirus vaccine against the virus Omicron strain. Rivian stock falls after shifting 2021 output forecast Shares of Amazon backed electric vehicle automaker Rivian Automotive Inc. fell by more than 10% during Fridays trading session after the firm made public its first-ever earnings report after going public.

Parthenon LLC cut its position in Pfizer Inc. (NYSE:PFE) by 4.0% during the third quarter, Holdings Channel reports. The firm owned 113,334 shares of the biopharmaceutical companys stock after selling 4,760 shares during the period. Parthenon LLCs holdings in Pfizer were worth $4,874,000 as of its most recent filing with the SEC. Other hedge funds []

Excalibur Management Corp lessened its holdings in shares of Pfizer Inc. (NYSE:PFE) by 1.7% in the 3rd quarter, Holdings Channel.com reports. The firm owned 157,026 shares of the biopharmaceutical companys stock after selling 2,777 shares during the quarter. Pfizer makes up approximately 3.0% of Excalibur Management Corps portfolio, making the stock its 6th largest position. []

Vaccine maker Pfizer said Friday that trials of its vaccine in children ages 2 to 5 show it did not provide the expected immunity in kids this age and it is adding a third dose to the regimen.

Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn''t appear strong enough for some of the children.

Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn''t appear strong enough for some of the children.